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Barriers to Peritoneal Dialysis in 
Aboriginal Patients
Anna T. Mathew1, Joonho Park2, Mala Sachdeva2, 
Manish M. Sood3, and Karen Yeates4
Abstract
Background: Aboriginal people in Canada have an unduly high burden of end-stage kidney disease (ESKD) and many live in 
rural settings. Peritoneal dialysis (PD) is a home-based dialysis modality that may provide a valuable alternative to in-center 
hemodialysis which is relatively underutilized by the Aboriginal population.
Objective: We aim to assess the barriers to PD utilization in Aboriginal patients with ESKD.
Design: This article is a prospective observational cohort study.
Setting: The setting involves 3 predialysis clinics in Winnipeg, Kingston, and Moose Factory.
Patients: The patients were 99 individuals (67 non-Aboriginal and 32 Aboriginal) who were at least 18 years of age with an 
estimated glomerular filtration rate of less than 30 mL/min/1.73m2, and were enrolled in one of the 3 study sites from April 
2011 to October 2013.
Measurements: Patient demographics and comorbidities were documented. Barriers to PD, PD as modality choice, and 
Aboriginal status were assessed via patient survey upon study enrollment. PD use as the initial dialysis modality was assessed 
via monthly patient follow-up for 1 year after enrollment in the study.
Methods: The patient survey was created based on literature review of known barriers to PD, repaired based on direct 
patient feedback, and tested for reliability via the test-retest method. Differences in PD choice, barriers to PD, and PD use 
between Aboriginal and non-Aboriginal patients were determined by chi-square test and logistic regression.
Results: All patients enrolled in the study completed the survey. Mean age was 65.5 versus 54.6 years for non-Aboriginals 
and Aboriginals, respectively. Barriers to PD significantly associated with Aboriginal status were lack of money (odds ratio 
[OR]: 21.3; 95% confidence interval [CI]: 5.3-86.4; P < .0001) and anxiety (OR: 2.8; 95% CI: 1.1-7.1; P = .03). There was no 
difference in PD choice between non-Aboriginals and Aboriginals (66.7% vs 68.8%, respectively; P = .83). One of 67 non-
Aboriginals (1.5%) and 5 of 32 Aboriginals (15.6%) died prior to initiating dialysis (P = .013). No significant difference was 
observed between non-Aboriginals (33%) and Aboriginals (28%) in use of PD (P = .81).
Limitations: Small sample size was a limitation of this study.
Conclusions: Aboriginal people in Canada have a disproportionately large burden of ESKD, and PD could provide an 
alternative to in-center hemodialysis for those living in rural areas. Our study identified anxiety and lack of money as barriers 
to PD significantly associated with Aboriginal status. When choosing dialysis modality, shared decision making between 
physicians and patient is of key importance to weigh all potential benefits and risks and emphasize the Aboriginal patient’s 
values and preferences. These results can be used to guide future research and to help devise interventions targeting barriers 
to PD in Aboriginals.
Abrégé 
Contexte: Au Canada, un nombre important de personnes autochtones habitent en région rurale, et cette population 
présente un taux exagérément élevé d’insuffisance rénale terminale (IRT) par rapport à la population générale. La 
dialyse péritonéale (DP) est une modalité de dialyse que le patient reçoit à domicile et qui pourrait s’avérer une 
solution de remplacement intéressante à l’hémodialyse en centre, laquelle est relativement sous-utilisée par les patients 
autochtones.
Objectif de l’étude: Nous voulions recenser les facteurs qui restreignent l’utilisation de la DP chez les patients autochtones 
souffrant d’IRT.
Type d’étude: Il s’agit d’une étude de cohorte observationnelle et prospective.
Cadre de l’étude: Trois cliniques de prédialyse situées à Winnipeg, à Kingston et à Moose Factory ont pris part à 
l’étude.
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Patients: La cohorte était constituée de 99 patients adultes (67 allochtones et 32 autochtones) dont le débit de filtration 
glomérulaire estimé (DFGe) était de moins de 30 ml/min/1,73 m2. Les participants à l’étude ont été recrutés parmi les 
patients des trois centres de prédialyse mentionnés ci-haut entre avril 2011 et octobre 2013.
Mesures: On a d’abord noté les données démographiques et les comorbidités des patients. Ensuite, un sondage réalisé 
auprès des patients au moment du recrutement a permis d’établir leur statut autochtone ou allochtone, de déterminer les 
facteurs qui constituaient un frein à leur utilisation de la DP, de même que des données sur l’usage de la DP comme modalité 
de dialyse. Le choix de la DP comme modalité initiale a été déterminé par un suivi mensuel sur une période d’un an post-
recrutement.
Méthodologie: Les obstacles à l’utilisation de la DP comme modalité de dialyse figurant dans le sondage étaient basés 
sur une revue de la littérature recensant ces facteurs. Le sondage a ensuite été modifié en fonction de la rétroaction 
offerte par les patients, et sa fiabilité a été évaluée par la méthode du test-retest. Les divergences observées entre le 
choix ou non de la DP comme modalité de dialyse, les facteurs freinant son utilisation et les variations relevées en regard 
de l’origine ethnique des patients (autochtones ou allochtones) ont été établies par le test du chi carré et par régression 
logistique.
Résultats: Tous les patients inclus dans l’étude ont répondu au sondage. L’âge moyen des patients allochtones était de 
65,5 ans alors qu’il était de 54,6 ans pour les patients autochtones. Les entraves à l’utilisation de la DP associées de façon 
significative avec le statut d’autochtone étaient le manque d’argent (RC=21,3; IC 95% 5,3-86,4; p<0,0001) et l’anxiété 
(RC=2,8; IC 95 1,1-7,1; p=0,03). Aucune différence n’a été observée entre allochtones et autochtones (66,7 % contre 68,8 
% respectivement; p=0,83) en ce qui concerne le choix de la DP comme modalité de dialyse. Un patient allochtone (1,5 
%) et 5 patients autochtones (15,6 %) sont décédés au cours de la période couverte par l’étude. Enfin, aucune variation 
significative n’a été observée entre les patients autochtones et allochtones (28 % et 33 % respectivement; p=0,81) en regard 
de l’utilisation de la DP comme modalité de dialyse.
Limites de l’étude: La taille restreinte de l’échantillon limite la portée de cette étude.
Conclusion: Au Canada, l’insuffisance rénale terminale affecte les patients autochtones de façon disproportionnelle. Pour 
ceux d’entre eux qui habitent en région rurale, la dialyse péritonéale, qui se pratique à domicile, pourrait s’avérer une 
solution de remplacement intéressante à l’hémodialyse conventionnelle qui elle, se pratique en centre hospitalier. Notre 
étude a révélé que l’anxiété et le manque d’argent constituaient des facteurs restreignant l’utilisation de la DP chez la 
population autochtone. Dans le choix d’une modalité de dialyse, la prise de décision conjointe du patient avec les médecins 
revêt une importance majeure : d’abord pour bien mesurer les bienfaits et les risques potentiels, mais également pour 
tenir compte des valeurs et des préférences du patient autochtone. Ces résultats pourront servir à orienter les recherches 
futures et à concevoir des interventions ciblant les facteurs qui freinent l’utilisation de la DP chez les patients autochtones 
atteints d’IRT.
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What was known before
Aboriginals in Canada have a high burden of end-stage kid-
ney disease and low utilization of peritoneal dialysis com-
pared with non-Aboriginals.
What this adds
Based on a self-reported patient survey, Aboriginals per-
ceive lack of money and anxiety as significant barriers to the 
use of peritoneal dialysis. In our patients, as in other cohorts, 
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risk of death before dialysis was higher in Aboriginal 
patients.
Introduction
Over 1.4 million people, 4.3% of Canada’s total population, 
self-identify as Aboriginal, encompassing First Nations, 
Inuit, and Metis.1 Aboriginal people in Canada have an 
unduly high burden of kidney disease, with a 4 times higher 
incidence rate of end-stage kidney disease (ESKD) than non-
Aboriginal people.2 While diabetes is the leading cause of 
ESKD in Aboriginal patients,3 a combination of medical and 
societal factors such as hypertension, vascular disease, glo-
merulonephritis,4 poverty, poor access to health care, and 
delayed referral to a nephrologist5 may all contribute to this 
growing burden of ESKD. Aboriginals also have a signifi-
cantly lower rate of renal transplantation than white patients 
in Canada.6 Consequently, there has been an 8-fold increase 
in the number of Aboriginal dialysis patients between 1980 
and 2000.7
Peritoneal dialysis (PD) is dialysis therapy that can be 
done at home. In prospective studies, approximately 64% to 
75% of ESKD patients are medically eligible for PD.8,9 In 
general, PD patients appear to have a lower mortality rate 
compared with hemodialysis (HD) patients in the first few 
years of treatment,10 lower cost, and an overall similar qual-
ity of life.8,11 The early survival benefits of PD may be due to 
preservation of residual renal function.12 As a home-based 
therapy, PD provides a valuable alternative for patients liv-
ing in remote areas. In-center HD is typically available only 
at larger centers that may require long travel distance 3 times 
per week for patients to receive HD. Despite this, the propor-
tion of incident patients on PD in Canada remained approxi-
mately 20% in 2015.13
Approximately half of Canada’s Aboriginal population 
lives outside urban centers, divided between reserves and 
nonreserve rural areas.1 Initiating in-center HD usually 
requires relocation to a larger and more urban center. For 
people living in the James Bay Coastal Region of Ontario, 
Moose Factory Island is the only site with an HD unit. 
Due to the remote geography and lack of year-round road 
access from communities up the coast from Moose 
Factory, patients in other communities cannot travel for 
weekly dialysis and must relocate if this is the selected 
modality. A qualitative study of Aboriginal patients who 
have relocated from their community to access HD 
describes a loss of community, cultural and spiritual isola-
tion as well as alienation from children and friends.14 To 
avoid relocation, it is plausible that Aboriginal patients 
with ESKD living in rural areas would choose PD as their 
chronic modality. However, in an observational study of 
incident Canadian dialysis patients,15 Aboriginals were 
less likely to initiate PD therapy compared with whites 
even though a significantly larger proportion lived in rural 
locations. Aboriginal patients were also more likely to 
switch from peritoneal to HD.
Prior studies have examined and devised targeted inter-
ventions to overcome barriers to PD. Medical, cognitive, 
psychological, and social barriers to PD, rather than absolute 
contraindications, often contribute to physician and patient 
preference to initiate HD. For example, age, comorbid condi-
tions, and living alone are positively associated with patient 
preference of HD.16 Thus, elderly patients over the age of 70 
are less likely to choose PD, even after completing predialy-
sis education.9 Measures to overcome these barriers, such as 
increasing home care assistance, have resulted in a signifi-
cant increase in PD uptake in the elderly population in 
Toronto, Canada.16
A series of studies also found an increased utilization of 
self-care dialysis when a knowledge barrier for a specific 
population was identified and an appropriate intervention 
was applied. An assessment of barriers to self-care dialysis 
was conducted in an in-center HD unit in Canada.17 Barriers 
were divided into 3 groups: knowledge, attitudes, and skills. 
Sixty percent of respondents reported that they lacked knowl-
edge in the various dialysis modalities. Frequent attitude bar-
riers were (a) the belief that patients should not be dialyzed 
without direct supervision (53%) and (b) fear of social isola-
tion (54%).The most frequent skills barrier was lack of space 
at home, reported by 42% of respondents. Following this sur-
vey, patients with chronic kidney disease (CKD) were 
enrolled in a randomized controlled trial and assigned to 
usual care, or a 2-phase educational intervention that tar-
geted these frequently identified barriers. Patients assigned 
to the education arm were significantly more likely to choose 
self-care dialysis.18 However, no prior studies have exam-
ined the unique barriers to PD in Aboriginals with ESKD.
The purpose of the study is to assess the medical, cultural, 
cognitive, and psychological barriers to PD utilization in 
Aboriginal patients. Results will be used to devise and imple-
ment a targeted intervention to increase PD use in this 
population.
Methods
Study Sites
Patients were enrolled at 3 different predialysis clinics located 
in Winnipeg, Kingston, and Moose Factory (Kingston satel-
lite). All patients in the predialysis clinic receive care and dialy-
sis modality education as per the local standard of care, by a 
multidisciplinary team comprised of a nephrologist, social 
worker, and nurse trained in dialysis modality education.
Patient Recruitment and Follow-up
Patients included in this study were required to be at least 18 
years of age and enrolled at one of the 3 study sites with an 
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estimated glomerular filtration rate of less than 30 mL/
min/1.73 m.2 Patients at these clinics represent a heteroge-
neous population inclusive of Aboriginal and non-Aboriginal 
patients from reserves, nonreserve rural areas, and urban 
centers. Patients who self-identified as First Nations, Inuit, 
or Metis were considered Aboriginal, and all others were 
considered non-Aboriginal. Patients were excluded from this 
study if they had an absolute contraindication for PD, includ-
ing a history of abdominal scarring, abdominal hernia, mor-
bid obesity, inflammatory bowel disease, diverticulitis, 
ileostomy, colostomy, ascites, abdominal vascular aneu-
rysms, large polycystic kidneys, or residence in a nursing 
home that does not permit PD.
Consecutive eligible patients were approached for study 
recruitment and enrolled after providing informed consent. 
Patient survey (see below) was administered by research 
staff immediately upon study enrollment. When required, 
translator services were provided to prevent selection bias 
for English-only speaking patients. Adherence to the 
Canadian Institutes for Health Research guidelines for health 
research involving Aboriginal people was maintained from 
recruitment of patients to the conclusion of this study. Patient 
recruitment occurred over a 3-year period, with 1-year fol-
low-up after enrollment.
Outcome Definitions
PD eligibility was defined as capability to conduct self-care 
PD as determined by the predialysis multidisciplinary team 
that assessed clinical factors which precluded patients from 
PD. These factors included but were not limited to impaired 
manual dexterity, poor vision or hearing, inadequate reading 
or writing ability, or inadequate space to perform PD.
PD choice was defined as patient choice of PD, as assessed 
by survey on patient enrollment into the study, prior to initia-
tion of any dialysis modality.
PD use was the primary study outcome, and defined as 
the first dialysis at home after completion of training.
Data Collection
Upon enrollment, patients completed a written survey (see 
below for details of survey design) identifying their choice of 
dialysis modality, Aboriginal status, and barriers to PD. 
Baseline demographics, comorbidities, and PD eligibility 
were recorded using medical chart review. Patients were fol-
lowed on a monthly basis for 1 year after enrollment to assess 
for initiation of dialysis, modality of dialysis utilized, mor-
tality, and transitions between PD and HD.
Survey Design and Validation
The patient survey used in this study was created based on 
literature review of known barriers to PD, repaired based on 
direct patient feedback, and tested for reliability via the 
test-retest method.19 First, a literature review was conducted to 
assess previously validated surveys regarding barriers to PD. 
A preliminary survey was created based on the literature and 
given to a pilot group of randomly selected Aboriginal and 
non-Aboriginal patients in the predialysis clinic. Sixteen 
patients (12 non-Aboriginal and 4 Aboriginal) were initially 
administered the survey, and then retested a month later. The 
preliminary survey was comprised of a series of binary ques-
tions and additionally had a section for open-ended questions 
to screen for additional barriers to PD. Additional and themati-
cally recurrent barriers to PD described by patients in the ini-
tial survey were integrated into the subsequent survey. The 
final survey consisted of 4 barrier domains and 20 barriers. 
The kappa statistic was calculated for each question using the 
test-retest method. Agreement was greater than 81% for all 
questions indicating excellent reliability. The survey was 
administered to patients by research staff immediately upon 
patient enrollment.
Sample Size Calculation
Sample size calculation was conducted by extrapolation of 
data from a prior retrospective study that examined PD use 
in patients both Aboriginal and non-Aboriginal patients at 
Kingston General Hospital.20 This study provided estimates 
on the proportion of Aboriginal and non-Aboriginal patients 
who initiate PD, which is consistent with the primary out-
come of our study. To detect a 58% standardized difference 
in this proportion (45% Aboriginal and 18% non-Aborigi-
nal patients) with 90% and a significance level of 0.05, a 
sample size of 124 patients was deemed necessary. This 
sample size calculation with continuity correction is based 
in the normal approximation to the binomial distribution 
and equal numbers of Aboriginal and non-Aboriginal 
patients.
Statistical Analysis
Baseline demographic characteristics were compared 
between Aboriginal and non-Aboriginal patients using a t 
test for continuous variables and chi-square test for cate-
gorical variables versus Fisher exact test as appropriate. 
The proportion of PD choice, eligibility, and use was com-
pared between groups using the chi-square test and logis-
tic regression. For self-identified barriers to PD, 
Aboriginal and non-Aboriginal responses were compared 
using the chi-square test and logistic regression analyses. 
In exploratory analysis, barriers associated with non-PD 
use were compared in Aboriginal and non-Aboriginal 
patients, and frequency of barriers associated with 
Aboriginals living remotely from dialysis center (>500 
km) were compared with other Aboriginals. For all analy-
ses, differences were considered significant a priori if the 
2-sided P value is less than .05. STATA version 12 was 
used for all analyses.
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Results
Baseline Demographics and Comorbidities
Patients were enrolled from 2011 to 2013, with follow-up 
completed in October 2014. A total of 99 participants were 
enrolled in this study consisting of 67 non-Aboriginal and 32 
Aboriginal patients (20 from Kingston, 3 from Moose 
Factory and 76 from Winnipeg locations). All patients who 
enrolled in the study completed the survey. Statistically sig-
nificant differences in demographic characteristics included 
mean age of participants (65.5 vs 54.6 years for non-Aborig-
inal and Aboriginal patients, respectively; P < .0001), and 
median distance from the study center (11 km vs 477 km for 
non-Aboriginal and Aboriginal patients, respectively; P 
value < .0001). Causes of ESKD, as documented in patient 
charts, were found to be significantly different between 
groups. Diabetes caused ESKD in 37.3% versus 84% in non-
Aboriginal versus Aboriginal, respectively (P < .0001). 
Hypertension caused ESKD in 14.9% versus 0% in non-
Aboriginal versus Aboriginal patients (P = .021). Patients in 
both groups had similar mean estimated glomerular filtration 
rates, body mass index (BMI), and total body weight at the 
time of enrollment (Table 1).
Barriers to PD
Among 20 different potential barriers across 4 domains 
assessed in this study, barriers to PD found to be significantly 
associated with Aboriginal status included lack of money 
(odds ratio [OR]: 21.3; 95% confidence interval [CI]: 5.3-
86.4; P < .0001) and anxiety (OR: 2.8; 95% CI: 1.1-7.1; P = 
.03). Lack of motivation, lack of social support, lack of fam-
ily support, and the belief that dialysis should be done in-
hospital trended to deter non-Aboriginals from PD, although 
none achieved statistical significance (Table 2).
In exploratory analysis, barriers associated with non-PD 
use were compared in Aboriginal and non-Aboriginal 
patients, and none were found to be significant. When com-
paring remote dwelling with other Aboriginals, there was no 
significant difference in the frequency of barriers to PD 
except for “lack of motivation” which was significantly 
higher in nonremote dwelling Aboriginals (50% vs 0; P = 
.004; Supplementary Table 1).
Patient Outcomes
Assessment by a multidisciplinary team yielded no statisti-
cally significant difference in PD eligibility between non-
Aboriginal versus Aboriginal patients (93.9% vs 87.5%, 
respectively; P = .27). In addition, no differences were 
demonstrated in PD choice between non-Aboriginal and 
Aboriginals, as identified by the patient survey (66.7% vs 
68.8%, respectively; P = .83). One of 67 non-Aboriginal 
patients (1.5%) and 5 of 32 Aboriginal patients (15.6%) 
died prior to initiating dialysis (P = .013). In addition, 9 
non-Aboriginal and 3 Aboriginal patients remained in CKD 
at the conclusion of this study and did not initiate dialysis, 
while 2 non-Aboriginals and 1 Aboriginal underwent a pre-
emptive kidney transplant (Table 3). Three non-Aboriginals 
and no Aboriginals were lost to follow-up prior to initiating 
dialysis.
Among the non-Aboriginal patients who initiated dialy-
sis (52 of 67 patients), only 40% (n = 21) initiated PD and 
the remaining 31 patients initiated HD. Among the 
Aboriginal patients who initiated dialysis (23 of 32 patients), 
only 39% (n = 9) initiated PD and the remaining 14 initiated 
HD. There was no statistically significant difference 
between the proportion of Aboriginal versus non-Aboriginal 
patients who initiated PD or HD. The proportion of dialysis 
patients who initiated PD, versus the proportion of enrolled 
Table 1. Baseline Demographics.
Non-Aboriginal (n = 67) Aboriginal (n = 32) P value
Mean age, y (SD) 65.5 (11.4) 54.6 (12.9) <.0001
% male 61.2 40.6 .06
Mean weight, kg (SD) 84.0 (23.4) 85.4 (18.9) .77
Mean BMI, kg/m2 (SD) 29.6 (6.8) 31.0 (6.5) .37
Mean eGFR, mL/min/1.73 m2 (SD) 10.9 (4.3) 10.3 (3.0) .47
Study center, number enrolled
 Kingston 19  4 —
 Winnipeg 48 28 —
Median distance from study center, km (IQR) 11 (4.7-91.1) 476.6 (38.4-569.1) <.0001
Cause of ESKD, n (%)
 Diabetes 25 (37.3) 27 (84.4) <.0001
 Hypertension 10 (14.9) 0 .021
 Glomerulonephritis 14 (20.9) 4 (12.5) .311
 Other 18 (26.9) 1 (3.1) .005
Note. BMI = body mass index; eGFR = estimated glomerular filtration rate; IQR = interquartile range; ESKD = end-stage kidney disease.
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patients who chose PD, was low in both Aboriginals (39% 
vs 68.8%) and non-Aboriginals (40% vs 66.7%). A similar 
proportion of patients also required a “crash start” to initiate 
HD in hospital in the non-Aboriginal and Aboriginal group 
(Table 3).
Very few patients had a switch in modality after initia-
tion of dialysis, precluding meaningful comparison or anal-
ysis. In non-Aboriginal patients, 4 patients who initiated 
HD subsequently switched to PD, and 3 of 21 patients who 
initiated PD had technique failure and switched to HD. In 
Aboriginal patients, no patients had PD technique failure, 
and 1 patient switched from HD to PD. A total of 4 non-
Aboriginal and 7 Aboriginal patients had died during the 
study period by the end of follow-up. A total of 3 non-
Aboriginal and 1 Aboriginal patients were transplanted by 
the end of follow-up period (Figure 1).
Table 2. Barriers Survey Completed by Patient.
Non-Aboriginal, n/N (%) Aboriginal, n/N (%) OR (95% CI) P value
Knowledge barriers
 Lack of awareness 0 0 NA NA
 Lack of explanation of options 1/67 (1.50) 1/32 (3.12) 2.12 (0.13-35.12) .60
 Lack of understanding 11/66 (16.7) 6/32 (18.8) 1.15 (0.38-3.4) .80
Medical barriers
 Lack of strength 10/67 (14.9) 5/32 (15.6) 1.05 (0.33-3.39) .93
 Lack of mobility 6/67 (9.0) 2/32 (6.3) 0.67 (0.13-3.6) .64
 Poor health status 4/67 (6.0) 4/32 (12.5) 2.25 (0.52-9.6) .27
 Poor vision 4/67 (6.0) 5/32 (15.6) 2.92 (0.73-11.71) .12
 Poor hearing 2/67 (3.0) 1/32 (3.1) 1.05 (0.09-12.01) .97
 Poor memory 3/67 (4.5) 2/32 (6.3) 1.42 (0.23-8.96) .71
Psychological barriers
 Anxious 14/62 (22.6) 14/31 (45.2) 2.82 (1.12-7.11) .03
 Afraid 14/66 (21.2) 9/32 (28.1) 1.45 (0.55-3.84) .45
 Dialysis should be done in-hospital 10/62 (16.1) 4/28 (14.3) 0.87 (0.25-3.04) .82
 Isolation 14/64 (21.9) 9/31 (29.03 1.46 (0.55-3.88) .45
 Lack of Motivation 29/65 (44.6) 10/31 (32.3) 0.59 (0.24-1.45) .25
Cultural and social barriers
 Language 2/67 (3.0) 4/32 (12.5) 4.64 (0.80-26.83) .08
 Lack of space 15/65 (23.1) 9/32 (28.1) 1.30 (0.50-3.42) .59
 Lack of time 6/66 (9.1) 3/31 (9.7) 1.07 (0.25-4.60) .93
 Lack of social support 15/66 (22.7) 5/32 (15.6) 0.63 (0.21-1.92) .41
 Family declines 16/58 (27.6) 5/23 (21.7) 0.73 (0.23-2.29) .59
 Lack of moneya 3/47 (6.4) 16/27 (59.3) 21.33 (5.23-86.42) <.0001
Note. OR = odds ratio; CI = confidence interval.
aAssessed only in Winnipeg patients.
Table 3. Study Outcomes.
Non-Aboriginal (n = 67) Aboriginal (n = 32) P value
PD eligibilitya (%) 62 (93.9) 28 (87.5) .27
PD choiceb 44 (66.7) 22 (68.8) .83
Died prior to starting dialysis (%) 1 (1.5) 5 (15.6) .013
Remained CKD 9 (13.4) 3 (9.4) .75
Preemptive transplant 2 (3.0) 1 (3.1) 1.00
Initiated dialysis (%) 52 (77.6) 23 (71.9) .71
 PD use for first dialysis (primary outcome) 21 (31.3) 9 (28.1) .81
 HD use for first dialysis 31 (46.3) 14 (43.8) .89
  Crash start HD in-hospitalc 9 (17.3) 5 (21.7) .76
Note. PD = peritoneal dialysis; CKD = chronic kidney disease; HD = hemodialysis.
aAssessed by multidisciplinary team.
bAssessed by patient.
cIn the subgroup of patients who started HD.
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Discussion
This prospective cohort study followed Aboriginal and non-
Aboriginal patients from 3 predialysis clinics with the objec-
tive of assessing PD use and associated barriers. We 
hypothesized that Aboriginals would have lower use of PD 
compared with non-Aboriginals. Barriers to PD were 
assessed by a patient survey administered prior to initiation 
of dialysis. Our results demonstrated no significant differ-
ence in PD use between non-Aboriginals and Aboriginals 
(31% vs 28%; P = .81). Aboriginal patients were signifi-
cantly more likely to die prior to initiation of dialysis com-
pared with non-Aboriginals (15.6% vs 1.5%; P = .013). Lack 
of money (OR: 21.33; 95% CI: 5.23-86.42; P < .0001) and 
anxiety (OR: 2.82; 95% CI: 1.12-7.11; P = .03) were identi-
fied as significant barriers to PD use in Aboriginal patients. 
Several other barriers trended to deter non-Aboriginal 
patients from PD, including lack of motivation, lack of social 
support, lack of family support, and the belief that dialysis 
should be done in-hospital, although none achieved statisti-
cal significance.
While our study did not demonstrate a significant differ-
ence in PD use, prior studies have demonstrated disparities 
in the use of PD in Aboriginals compared with non-Aborigi-
nals. Tonelli et al reviewed 3823 incident dialysis patients 
from Alberta, Manitoba, or Saskatchewan using data from 
the Canadian Organ Replacement Registry. They report that 
after adjustment for age and comorbid features, Aboriginals 
were less likely to initiate PD than white patients (OR: 0.51; 
95% CI: 0.40-0.65). This disparity in Aboriginal health care 
use extends to renal transplantation6 and also general health 
care utilization.21 Our sample size and duration of follow-up 
were too limited to determine survival after dialysis initia-
tion. However, other studies assessing associations of dialy-
sis modality and mortality in Canadian Aboriginals have had 
conflicting results. Sood et al report a study of the incident 
Canadian dialysis population using administrative data 
where Aboriginals on PD had higher mortality than 
Caucasians on PD (hazards ratio: 1.36; 95% CI: 1.13-1.62),22 
as well as higher PD technique failure rates. These findings 
may be related to marginal PD candidates who are Aboriginal 
choosing PD to remain in their communities, thus resulting 
in an association with mortality and technique failure. 
However, Tonelli et al report no significant difference in 
mortality between Aboriginal and non-Aboriginal incident 
PD patients (HR: 1.00; 95% CI: 0.71-1.40).15 While these 
retrospective observational studies all attempted to adjust 
extensively for relevant covariates, residual confounding is 
still a potential limitation to interpretation. As approximately 
half of Aboriginal people live outside urban areas, both on 
and off reserve, PD may offer a valuable modality choice 
which avoids the need to move to an urban area to access an 
in-center HD unit. Given the uncertainty in the literature 
regarding potential adverse outcomes, initiation of PD in 
Aboriginal patients requires careful and individualized 
shared decision making to weigh all potential benefits and 
risks and emphasize the Aboriginal patient’s values and 
preferences.
Figure 1. Study flow.
Note. CKD = chronic kidney disease; PD = peritoneal dialysis; HD = hemodialysis.
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We report a higher risk of death prior to initiation of dialy-
sis in Aboriginal compared with non-Aboriginal patients. 
This finding is in line with the existing literature on the high 
risk of mortality in Aboriginal patients with CKD,2 perhaps 
related to reduced access to care5 or remote dwelling.23 
However, a complex interplay of cultural, socioeconomic, 
medical, and psychological factors all contribute to the dis-
proportionate mortality observed in Aboriginal patients and 
requires further study.
In this study, we report that barriers to PD significantly 
associated with Aboriginal status included anxiety and lack 
of money. These findings have not been previously pub-
lished, but are not surprising given the existing literature on 
Aboriginal mental health and socioeconomic status. 
Carrière et al examined 2006 Canadian national census 
data, linked to the Discharge Abstract Database to describe 
patterns of hospitalization by Aboriginal identity.24 
Compared with non-Aboriginals, First Nations living on 
reserve had a 3.6 times higher rate of hospitalization for 
mental and behavioral disorders. Firestone et al conducted 
a survey of 554 First Nations adults living in Hamilton, 
Ontario, to assess the prevalence of mental health disor-
ders, and found 39% of respondents met criteria for anxiety 
and/or depression.25 Income disparity has also been well-
documented in Canada’s Aboriginal population, contribut-
ing to our finding of lack of money as a significant barrier 
to PD in Aboriginal patients. In a report from the Canadian 
Center for Policy Alternatives, Wilson and Macdonald 
examined data from the 1996, 2001, and 2006 Canadian 
census to measure the income gap between Aboriginals and 
non-Aboriginals.26 In 2006, the median income for 
Aboriginal peoples was $18 962, 30% lower than the 
$27 097 median income in non-Aboriginals, with income 
gaps persist regardless of urban or rural residence. In this 
study, we also report that several factors trended as a barrier 
to deter non-Aboriginal patients from PD, including lack of 
motivation, lack of social support, lack of family support, 
and the belief that dialysis should be done in-hospital. It is 
of interest to note the trend that social factors in general do 
not seem to present a substantial barrier to PD for Aboriginal 
patients in this study, a finding which requires further study. 
It is interesting that participants reported lack of money as 
a barrier despite having quite comprehensive coverage for 
overall health care specifically for ESKD. This highlights a 
possible fundamental misconception that there would be 
associated costs with PD. This may reflect the educational 
program on dialysis modality selection and highlights a 
potential area for improvement. Even when accounting for 
deaths prior to initiating dialysis, preemptive transplanta-
tion, and modality switches after dialysis initiation, the pro-
portion of patients in the study who chose PD still remained 
substantially higher than those who used PD. While our 
observational study did not collect additional patient or 
provider data to discern barriers to switching from HD to 
PD after dialysis initiation, this is an important topic for 
further study.
Several limitations could affect interpretation of the 
results of this study. First, despite extending the original 
planned 2-year enrollment period by a year, we were unable 
to enroll enough Aboriginal patients to meet our original 
sample size requirements. Thus, while our findings are 
underpowered to detect differences in the primary outcome 
of PD use, our findings related to barriers to PD in Aboriginals 
provide novel information which can be used for future 
research. Second, inherent to survey-based studies are biases 
that are difficult to correct. Not all survey questions were 
completed by all patients, leading to some missing data. 
Disenfranchised populations such as Aboriginal patients 
may be less inclined to participate in research, and Aboriginal 
patients who agreed to enroll in the study may be more moti-
vated and thus more likely to initiate PD. Also, despite the 
demonstrated high reliability of the survey tool, participant-
dependent response bias is difficult to control and can never 
be fully eliminated.
Third, “lack of money” was identified as a potential bar-
rier by patients and study personnel at the Winnipeg site, and 
subsequently added to the survey. Thus, data on this variable 
are available only for Winnipeg patients (n = 76) and not 
those recruited from Kingston or Moose Factory (n = 23). 
Despite this lack of barrier data for some patients in the 
study, “lack of money” had a significant association with 
Aboriginal status. Finally, our observational study cannot 
fully address the complex cultural barriers to PD in the 
Aboriginal population, which would be best assessed using 
qualitative methodology.
In conclusion, Aboriginal people in Canada have an 
unduly high burden of kidney disease, with disproportion-
ately high rates of ESKD and lower rates of transplantation 
compared with non-Aboriginals. Half of Canada’s 
Aboriginal population lives in rural locations, and PD pro-
vides a valuable alternative to in-center HD for these remote 
dwelling patients. Our study identified anxiety and lack of 
money as barriers to PD significantly associated with 
Aboriginal status. These results can be used for future 
research to devise targeted interventions to overcome these 
barriers, including standardized predialysis education ses-
sions. Given the complex interplay of cultural, socioeco-
nomic, medical, and psychological factors when choosing 
dialysis modality, shared decision making between physi-
cians and patients to weigh all potential benefits and risks 
and emphasize the Aboriginal patient’s values and prefer-
ences is of key importance.
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